Time-critical oxygen delivery.
Trauma, hemorrhage, EMS, HEMS, remote and humanitarian environments can expose the logistical limits of conventional blood access.
Human-use evidence ↗Applications
Where oxygen delivery matters.
BHOC Therapeutics focuses on clinical and translational environments in which oxygen delivery can become a central physiological problem. These areas are fields of scientific and development interest, not approved therapeutic claims.
Perfusion and preservation.
Liver, kidney, heart and cross-organ research includes oxygenated perfusion, preservation and viability assessment.
Transplantation evidence ↗Clinical and regulatory precedent.
Veterinary medicine provides an important evidence base for oxygen-carrier development, including Oxyglobin regulatory history and animal-use literature.
Veterinary evidence ↗Severe anemia and critical care context.
Human-use research spans acute and severe anemia, surgery, cardiovascular stress, critical care and circumstances in which donor blood may be unavailable or unsuitable.
Human-use evidence ↗When transfusion is delayed or not an option.
Scientific interest extends to bloodless medicine, resource-limited care, austere medicine and other settings where oxygen-delivery options may need to bridge a temporary gap.
Supply-demand mismatch.
Ischemia, hypoxia and cardiac emergencies illustrate the difference between oxygen present in circulation and oxygen effectively available to stressed tissue.
Application evidence
Each application is linked to its own evidence context.
Use BHOC-platform to search publications, institutions, journals, years and source records across Veterinary, Transplantation and Human Use.